A study of the response to neoadjuvant chemotherapy in locally advanced breast cancer showed that serum TNF-α levels were significantly lower both in partial and complete response compared to pre-treatment (p < 0.01), there was also a significant difference in TNF-α levels between complete and partial response after treatment (23). Here, TNF is linked to breast carcinoma.